Sound waves vs. tumors: new device aims to zap abdominal cancers without a single cut
NCT ID NCT07180706
First seen Sep 30, 2025 · Last updated Jun 23, 2026 · Updated 33 times
Summary
This trial tests a device called histotripsy, which uses focused ultrasound waves to break apart solid tumors in the abdomen without surgery or needles. The goal is to relieve symptoms like pain caused by tumors that cannot be removed surgically. Thirty adults with inoperable abdominal tumors will receive the treatment and be monitored for quality of life, pain levels, and tumor shrinkage over six months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Taiwan University Hospital
Taipei, 100, Taiwan
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Histotripsy (non-invasive focused ultrasound device)
What this could lead to
If it works, this could offer a non-invasive way to shrink abdominal tumors and ease pain or discomfort without surgery or needles.
What could go wrong
This is a small, early-stage trial with only 30 people, so results may not apply broadly. The device is not yet approved in Taiwan, and risks like incomplete tumor destruction or side effects are still being studied.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.